As of 2025-05-07, the Relative Valuation of Bellicum Pharmaceuticals Inc (BLCM) is (176.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.62 USD, the upside of Bellicum Pharmaceuticals Inc based on Relative Valuation is -28401.9%.
The range of the Relative Valuation is (138.95) - (193.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.8x - 12.4x | 8.7x |
| Forward P/E multiples | 8.9x - 18.4x | 13.8x |
| Fair Price | (138.95) - (193.41) | (176.04) |
| Upside | -22439.7% - -31194.4% | -28401.9% |
| Date | P/E |